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Abstract
Objective:  To  assess  the  prevalence  of  vitamin  D  deﬁciency  and  its  associated  factors  in  women
and their  newborns  in  the  postpartum  period.
Methods:  This  cross-sectional  study  evaluated  vitamin  D  deﬁciency/insufﬁciency  in  226  women
and their  newborns  in  Vic¸osa  (Minas  Gerais,  BR)  between  December  2011  and  November  2012.
Cord blood  and  venous  maternal  blood  were  collected  to  evaluate  the  following  biochemical
parameters:  vitamin  D,  alkaline  phosphatase,  calcium,  phosphorus  and  parathyroid  hormone.
Poisson regression  analysis,  with  a  conﬁdence  interval  of  95%,  was  applied  to  assess  vitamin  D
deﬁciency and  its  associated  factors.  Multiple  linear  regression  analysis  was  performed  to  iden-
tify factors  associated  with  25(OH)D  deﬁciency  in  the  newborns  and  women  from  the  study.  The
criteria for  variable  inclusion  in  the  multiple  linear  regression  model  was  the  association  with
the dependent  variable  in  the  simple  linear  regression  analysis,  considering  p<0.20.  Signiﬁcance
level was  ˛  <5%.
Results:  From  226  women  included,  200  (88.5%)  were  20--44  years  old;  the  median  age  was
28 years.  Deﬁcient/insufﬁcient  levels  of  vitamin  D  were  found  in  192  (85%)  women  and  in  182
(80.5%) neonates.  The  maternal  25(OH)D  and  alkaline  phosphatase  levels  were  independently
associated  with  vitamin  D  deﬁciency  in  infants.
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2015.01.006
∗ Corresponding author.
E-mail: mara.prado@ufv.br (M.R.M.C. Prado).
359-3482/© 2015 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights reserved.
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Conclusions:  This  study  identiﬁed  a  high  prevalence  of  vitamin  D  deﬁciency  and  insufﬁciency
in women  and  newborns  and  the  association  between  maternal  nutritional  status  of  vitamin  D
and their  infants’  vitamin  D  status.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Prevalência  de  deﬁciência  de  vitamina  D  e  fatores  associados  em  mulheres  e  seus
recém-nascidos  no  período  pós-parto
Resumo
Objetivo:  Avaliar  a  prevalência  de  deﬁciência  de  vitamina  D  e  os  fatores  associados  em  mulheres
e recém-nascidos  no  período  pós-parto.
Métodos:  Estudo  de  delineamento  transversal;  avaliou-se  a  deﬁciência/insuﬁciência  de  vitam-
ina D  em  226  mulheres  e  seus  recém-nascidos  no  município  de  Vic¸osa  (MG),  entre  dezembro  de
2011 e  novembro  de  2012.  Coletaram-se  5mL  de  sangue  do  cordão  umbilical  e  sangue  venoso
materno  a  ﬁm  de  avaliar  os  parâmetros  bioquímicos:  vitamina  D,  fosfatase  alcalina,  cálcio,
fósforo e  paratormônio.  Usou-se  regressão  de  Poisson  e  adotou-se  a  Razão  de  Prevalência  (95%
IC), a  ﬁm  de  se  avaliar  a  deﬁciência  de  vitamina  D  e  fatores  associados.  Fez-se  a  análise  de
regressão  linear  múltipla  para  identiﬁcar  os  fatores  associados  à  deﬁciência  de  25(OH)D  dos
recém-nascidos  e  das  mulheres  do  estudo.  O  critério  para  inclusão  das  variáveis  na  regressão
linear múltipla  foi  a  relac¸ão  com  a  variável  dependente  na  análise  de  regressão  linear  simples,
considerando  p<0,20.  O  nível  de  signiﬁcância  adotado  foi  <5%.
Resultados:  Das  226  mulheres,  200  (88,5%)  tinham  entre  20  e  44  anos;  a  mediana  foi  de  28.
Encontrou-se  prevalência  de  níveis  deﬁcientes/insuﬁcientes  de  vitamina  D  em  192  (85%)  mul-
heres e  182  (80,5%)  recém-nascidos.  A  25(OH)D  materna  e  a  fosfatase  alcalina  materna  se
comportaram  como  preditores  independentes  da  deﬁciência  de  vitamina  D  dos  recém-nascidos.
Conclusões:  Foi  possível  identiﬁcar  a  alta  prevalência  de  deﬁciência  e  insuﬁciência  de  vitamina
D nas  mulheres  e  recém-nascidos  em  nosso  meio  e  a  relac¸ão  entre  o  estado  nutricional  materno
de vitamina  D  e  o  do  recém-nascido.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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Maternal--fetal  vitamin  D  deﬁciency  (VDD)  is  currently
a  frequent  morbidity.  Lifestyles,  environmental  factors
(inadequate  sunlight  exposure),  lack  of  vitamin  D  (VD)
supplementation  for  children  and  pregnant  women  and
insufﬁcient  intake  of  that  vitamin  and/or  calcium  are
responsible  for  the  high  prevalence  of  VDD  in  developed  and
developing  countries.1--3
VDD  in  a  pregnant  woman  and  her  newborn  (NB)  is  closely
associated.4 There  is  a  greater  transfer  of  25(OH)D  to  the
fetus  via  the  placenta  during  the  last  months  of  pregnancy,
which  is  the  main  source  of  this  vitamin  for  infants  during  the
ﬁrst  months  of  life.5,6 Additionally,  the  placenta  contains  VD
receptors  and  produces  the  enzyme  that  converts  25(OH)D
into  its  active  form,  thereby  increasing  VD  levels  for  the
fetus.5
In  the  ﬁrst  six  to  eight  weeks  of  postnatal  life,  the  NB’s
VD  status  depends  on  the  VD  acquired  by  placental  transfer
in  the  uterus,  as  demonstrated  by  its  direct  association  with
6,7the  levels  found  in  maternal  blood. In  most  NBs,  VD  stock
acquired  from  the  mother  run  out  up  to  the  eighth  week  of
life.7
u
a
VStudies  carried  in  India,  United  States,  Bangladesh,  Korea
nd  other  parts  of  the  world  have  shown  that  many  chil-
ren  worldwide  are  born  with  low  VD  reserves  as  a  result
f  high  maternal  VDD,  with  a  high  prevalence  of  deﬁ-
iency/insufﬁciency  of  25(OH)D,  ranging  from  22.3%  to
3.6%  and,  therefore,  at  risk  of  rickets.1,8--11 Normal  plasma
evels  of  VD  promote  the  absorption  of  30%  of  dietary  cal-
ium  and  more  than  60--80%  during  periods  of  growth,  due
o  the  high  calcium  demand.  Therefore,  during  childhood,
DD  can  cause  growth  retardation  and  bone  abnormalities,
ncreasing  the  risk  of  fractures  later  in  life.12 Additionally,
ow  levels  of  25(OH)D  in  cord  blood  were  associated  with
ncreased  risk  of  acute  respiratory  infections  and  wheezing
n  childhood.13
In  most  individuals,  skin  synthesis  is  the  major  source
f  VD  and  the  remainder  is  obtained  through  diet  and
upplements.1 Risk  factors  for  nutritional  rickets  are:  lat-
tude,  use  of  clothing  covering  most  of  the  body,  time  of
unlight  exposure,  increased  skin  pigmentation,  diets  high
n  vegetables  and  low  in  calcium,  exclusive  breastfeeding,
se  of  sunscreens  and  lifestyle. VDD  during  pregnancy  is
 worldwide  public  health  problem.  Studies  have  reported
DD  prevalence  ranging  from  18%  to  84%,  depending  on
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he  country  and  local  clothing  customs.1,4,8,9,13 However,  to
ate,  there  has  been  no  study  on  the  prevalence  of  VDD  in
razil  in  newborns  and  women  in  the  immediate  postpartum
eriod.  Given  the  magnitude  of  this  problem  in  the  popula-
ion,  the  aim  of  this  study  was  to  evaluate  the  prevalence
f  vitamin  D  deﬁciency  and  associated  factors  in  women  and
heir  newborns  in  the  postpartum  period.
ethod
his  was  a  cross-sectional  study,  approved  by  the  Inter-
ational  Review  Board  of  Universidade  Federal  de  Vic¸osa
n.  211/2011).  A  total  of  226  women  and  their  newborns
ere  evaluated  in  the  postpartum  period,  between  Decem-
er  2011  and  November  2012.
Sample  calculation  was  performed  using  EpiInfo  software
.0.  For  the  calculation,  we  obtained  the  number  of  new-
orns  living  in  the  city  in  2010,  adding  up  806  children.  We
sed  a  prevalence  of  VDD  estimated  at  20%10 and  95%  conﬁ-
ence  level.  To  the  number  of  188  obtained  at  the  sample
ize  calculation,  we  added  20%  for  possible  losses,  resulting
n  226  pairs  of  mothers  and  newborns.
Children  born  at  the  study  hospital  in  Vic¸osa,  with  ges-
ational  age  ≥37  weeks  and  whose  mothers  signed  the
nformed  consent  form,  were  included  in  the  study.  Infants
hat  were  admitted  to  the  Neonatal  Intensive  Care  Unit,
orn  with  congenital  malformations,  syndromes  and  the
esult  of  twin  pregnancies  were  excluded.
Obstetric  and  NB  data  (weight,  length,  head  circumfer-
nce,  ethnicity)  were  obtained  from  the  Obstetrics  Book
nd  Birth  certiﬁcates  (BC).  Socioeconomic  and  prenatal  care
ata  (including  sunlight  exposure,  use  of  sunscreens  and
ultivitamin  supplements)  were  obtained  through  a  ques-
ionnaire  applied  to  women  after  30  days  postpartum  at  the
ity’s  Polyclinic.  The  Brazilian  Criteria  for  Economic  Clas-
iﬁcation  (ABEP)  was  used  for  socioeconomic  classiﬁcation,
hich  takes  into  account  the  ownership  of  consumer  goods
nd  the  family  head’s  level  of  schooling.16
The  skin  color  of  the  mother  and  their  newborns  was
elf-reported  and  conﬁrmed  in  the  BC  by  researchers  when
he  questionnaire  was  applied,  and  it  was  categorized  as
aucasian  or  non-Caucasian.  The  sample  was  divided  into
wo  groups  according  to  the  time  of  sunlight  exposure
uring  pregnancy:  adequate  (>60  min/week)  or  inadequate
≤60  min/week).17
Plasma  levels  of  25(OH)D,  alkaline  phosphatase  (AP),
arathyroid  hormone  (PTH),  calcium  (Ca)  and  phosphorus
P)  were  evaluated  in  the  women  and  their  newborns  in  the
ostpartum  period,  by  collecting  5mL  of  cord  blood  and  5mL
f  maternal  venous  blood  for  biochemical  in  Vacuette® gel
ubes.  Serum  was  separated  in  a  refrigerated  centrifuge,
ivided  into  aliquots  and  stored  at  −20 ◦C  until  the  analyses
ere  performed.  Ca  was  measured  by  colorimetric  end-
oint  Calcium  Arsenazo  III,18 and  AP  by  Kinetic--IFCC  method
Bioclin).18 25(OH)D  levels  were  measured  by  Liaison®  com-
etitive  chemiluminescence  immunoassay  (CLIA-DiaSorin),19
nd  PTH  in  a  Beckman  immunochemiluminometric  assay  by
oulter®.18 p  was  obtained  by  UV  endpoint.18
The  sample  was  divided  into  two  groups  according  to
he  VD  levels  of  newborns  and  the  women:  VD  sufﬁciency
nd  non-sufﬁciency  (VD  insufﬁciency  and  deﬁciency).  VDD
b
(
b
(M.R.M.C.  do  Prado  et  al.
or  women  and  children  was  deﬁned  as  25(OH)D  <20ng/mL;
he  insufﬁciency  of  25(OH)D  between  ≥20  and  <30ng/mL,
nd  sufﬁciency  as  25(OH)D  levels  ≥30ng/mL.10 The  cutoff
or  high  PTH  was  46pg/mL;  for  hypocalcemia,  plasma  cal-
ium  levels  <9mg/dL  for  children  and  <8.8mg/dL  for  the
omen;  AP  was  considered  high  when  ≥375  U/L  for  infants
nd  100U/L  for  the  women.9
The  analysis  was  performed  using  the  IBM® SPSS® soft-
are,  release  20.0  for  Windows  (SPSS,  Chicago,  IL,  USA)  and
TATA  version  9.1  (Stata  Corp.,  College  Station,  TX,  USA).
he  Kolmogorov--Smirnov  test  was  used  to  assess  the  nor-
ality  of  the  quantitative  variables.  Categorical  variables
ere  analyzed  using  Poisson  regression  and  as  magnitude
easure,  we  used  the  prevalence  ratio  (PR)  and  their
espective  95%  conﬁdence  intervals  (95%  CI)  to  evaluate  non-
ufﬁciency  of  VD.  Spearman’s  correlation  was  calculated
etween  25(OH)D  and  the  variables  AP,  PTH,  Ca  and  P  of  the
omen  and  newborns.  Mann--Whitney  test  was  used  to  com-
are  the  levels  of  Ca,  PTH,  25(OH)D,  P  and  AP  between  the
omen  and  infants  with  VD  sufﬁciency  and  non-sufﬁciency.
Multiple  linear  regression  analysis  was  performed  to
dentify  factors  associated  with  25(OH)D  deﬁciency  in  the
ewborns  and  the  women  participating  in  the  study.  The  cri-
erion  deﬁned  for  inclusion  of  variables  in  the  multiple  linear
egression  was  the  association  with  the  dependent  variable
t  the  simple  linear  regression  analysis,  considering  a  value
f  p<0.20.  Statistical  signiﬁcance  level  was  set  at  ˛  <5%.
esults
f  the  226  mothers  and  their  newborns  assessed  in  the
tudy,  200  women  (88.5%)  were  aged  between  20  and  44
ears  (mean  28  years),  and  26  (11.5%)  were  adolescents.
egarding  ethnicity,  118  (52.2%)  women  reported  being  Cau-
asian.  It  is  noteworthy  that  62  (43.5%)  participants  had
 years  or  less  of  schooling,  192  (85%)  lived  in  the  urban
rea  and  176  (77.9%)  lived  with  a  partner.  It  was  observed
hat  152  (67.3%)  had  more  than  one  child.  Regarding  the
ype  of  delivery,  179  (79.2%)  underwent  a  cesarean  sec-
ion.  During  pregnancy,  142  (97.3%)  women  reported  taking
 multivitamin  supplement,  79  (54.1%)  did  not  meet  the
un  exposure  recommendations  and  91  (40.3%)  reported  not
sing  sunscreen.  There  was  no  association  (p>0.05)  between
he  levels  of  25(OH)D  identiﬁed  in  the  women  and  age,  eth-
icity,  schooling,  marital  status,  parity,  place  of  residence,
ype  of  delivery,  vitamin  supplement  intake,  sunlight  expo-
ure  or  use  of  sunscreens.
Of  the  newborns,  117  (51.8%)  were  females  and  119
52.7%)  were  Caucasian.  The  infants’  mean  gestational
ge  and  weight  were  38.7±1.0  weeks  and  3248±446g,
espectively;  the  infants’  length  was  48.8±2.1cm,  and  head
ircumference  was  33.9±1.5cm.  There  was  no  associa-
ion  between  the  infants’  levels  of  25(OH)D  and  gender,
thnicity,  season  of  the  year,  weight,  length  and  head  cir-
umference  or  gestational  age.
There  was  no  difference  in  the  levels  of  Ca,  AP,  P  and  PTH
etween  the  women  with  VD  sufﬁciency  and  non-sufﬁciency
Table  1).  However,  there  were  differences  in  plasma  levels
etween  newborns  with  VD  sufﬁciency  and  non-sufﬁciency
p<0.001)  and  calcium  levels  (p<0.03).  There  was  no  differ-
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Table  1  Biochemical  parameters  of  women  and  their  newborns  classiﬁed  according  to  the  sufﬁciency  or  not  of  25(OH)D  in  the  postpartum  period.
Women Newborns
Non-sufﬁciency Sufﬁciency Non-sufﬁciency Sufﬁciency
n (%)
Inadequacy
Mean
(SD)
Median
(min--max)
Mean
(SD)
Median
(min--max)
p-value n (%)
Inadequacy
Mean
(SD)
Median
(min--max)
Mean
(SD)
Median
(min--max)
p-value
AP U/L 100 (84.2)↑ 102.3 (2.5) 98.0 (34--232) 92.3 (6.9) 80.0 (42--187) 0.06 44 (19.5)↓ 108.2 (2.8) 104.0 (48--290) 113.8 (7.3) 107.0 (40--236) 0.57
CA  mg/dL 34 (15.5)↓ 9.4 (0.1) 9.0 (4--11) 9.3 (0.1) 9.0 (8--11) 0.55 8 (3.5)↓ 10.1 (0.1) 10.0 (8--12) 9.8 (0.1) 10.0 (8--11) 0.03
P  mg/dL 06 (2.7)↑ 13.8 (0.7) 4.0 (2--6) 13.7 (1.4) 4.0 (3--30) 0.86 7 (3.1)↓ 2.4 (0.3) 5.0 (3--7) 2.5 (0.5) 5.0 (3--7) 0.92
PTH  picog/mL -- 3.9 (0.04) 12.0 (1--67) 4.0 (0.2) 12.0 (3--30) 0.74 190 (84.2)↓ 4.7 (0.1) 1.0 (1--28) 4.7 (0.1) 1.0 (1--14) 0.62
25(OH)D  ng/mL 192 (85) 21.1 (0.4) 22.0 (8--30) 35.0 (0.9) 33.0 (30--50) <0.001 182 (80.5) 21.4 (0.4) 22.0 (8--30) 34.7 (0.6) 34.0 (30--48) <0.001
AP, alkaline phosphatase; CA, calcium; P, phosphorus; PTH, parathyroid hormone; ↑, plasma levels above the reference values; ↓, plasma levels below the reference values.
290  M.R.M.C.  do  Prado  et  al.
Table  2  Possible  factors  associated  with  non-sufﬁciency  of  vitamin  D  in  women  in  the  postpartum  period.
Non-sufﬁciencyc Sufﬁciency  PR  (95%  CI)  pa
n  %  n  %
Season  of  the  year
Fall  42  21.9  9  26.5  1  0.40
Other seasons  150  78.1  25  73.5  0.95  (0.87--1.05)
Ethnicity
Caucasian 100  52.1  18  52.9  1  0.92
Non-Caucasian  92  47.9  16  47.1  1.00  (0.90--1.12)
Sunlight exposure  during  pregnancyb
Yes 41  37.5 4  16.0  1  0.054
No 80  62.5 21  84.0 1.10  (0.99--1.22)
Multivitamin  supplementsb
Yes  120  97.6  22  95.7  1  0.68
No 3  2.4  1  4.3  0.88  (0.50--1.57)
Place of  residence
Rural  32  16.7  2  5.9  1  0.14
Urban 160  83.3  32  94.1  0.35  (0.08--1.40)
Sunscreen protection  in  pregnancyb
Yes 47  38.2 8  34.8  1  0.75
No 76  61.8 15  65.2  0.97  (0.84--1.12)
PR prevalence ratio; 95% CI, conﬁdence interval.
a Poisson regression.
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c Non-sufﬁciency (deﬁciency + insufﬁciency of vitamin D).
nce  regarding  the  levels  of  AP,  P  and  PTH  between  infants
ith  VD  sufﬁciency  and  non-sufﬁciency  (Table  1).
VDD  occurred  in  61  women  (27%)  and  66  newborns
29.2%);  131  women  (58%)  and  116  infants  (51.3%)  had
D  insufﬁciency,  and  only  34  women  (15%)  and  44  (19.5%)
ewborns  showed  VD  sufﬁciency.  Severe  VDD  (VD  lev-
ls  ≤0ng/mL)  was  observed  in  15  women  (11.9%)  and  4
ewborns  (1.8%).
There  was  no  association  between  VD  non-sufﬁciency  in
omen  or  the  newborns  and  season  of  the  year,  ethnicity,
lace  of  residence,  sunlight  exposure,  use  of  multivitamin
upplement  and  sunscreen  use  (Tables  2  and  3).
When  performing  the  multiple  regression  analysis  to
stimate  the  inﬂuence  of  obstetric,  biological  and  socioeco-
omic  variables  in  relation  to  the  mothers’  VDD,  variables
ith  p≤0.20  were  included  in  the  model:  maternal  school-
ng  (p=0.02),  place  of  residence  (p=0.11),  sunlight  exposure
p=0.16)  and  ABEP  classiﬁcation  (p=0.04).  In  the  ﬁnal  model,
here  was  no  statistically  signiﬁcant  association  of  these
ariables  with  maternal  VDD.
When  performing  the  multivariate  regression  to  estimate
he  inﬂuence  of  these  variables  in  relation  to  the  newborns’
DD,  variables  with  p≤0.20  were  included  in  the  model:
eason  of  birth  (p=0.06),  NB  ethnicity  (p=0.19),  maternal
5(OH)D  (p<0.001)  NB  Ca  (p=0.15)  and  maternal  alkaline
hosphatase  (p=0.0).  Maternal  levels  of  25(OH)D  and  alka-
ine  phosphatase  behaved  as  independent  predictors  of  VDD
n  the  newborns  (Table  4).  This  model  accounted  for  58%  of
he  variation  in  VD  levels  of  the  newborns  (Table  4).
When  using  Spearman’s  correlation,  we  observed  an
ssociation  between  PTH  and  25(OH)D  of  the  newborns
i
a
o
sr=−0.142;  p=0.033;  R2 =0.006),  with  a  strong  association
etween  maternal  and  newborn  levels  of  25(OH)D  (r=0.73;
<0.0001;  R2 =0.558).
iscussion
itamin  D  deﬁciency  is  a  worldwide  public  health  problem
nd  Brazil  is  part  of  this  scenario,  with  a  high  prevalence  of
DD  in  the  population,  as  demonstrated  by  studies  at  dif-
erent  age  groups.20 However,  no  studies  have  evaluated
aternal  and  NB  VDD  as  the  present  study.  We  found  a
igh  prevalence  of  VD  insufﬁciency,  of  80.5%  and  85%  in
ewborns  and  women,  respectively,  although  97.3%  of  the
omen  reported  the  use  of  multivitamin  supplements  during
regnancy.  In  India,  66.7%  of  VDD  was  found  in  the  chil-
ren  and  81.1%  in  the  mothers.  In  Korea,  18%  of  the  infants
ad  VDD  and  73.6%  had  VD  insufﬁciency  at  birth.  In  the
SA,  rates  of  22.3%  of  VDD  and  73.6%  of  VD  insufﬁciency
ere  identiﬁed  in  290  babies,  and  VD  insufﬁciency  was  also
dentiﬁed  in  several  countries.8--11,13,21 Reports  in  the  liter-
ture  have  shown  that  the  lack  of  or  inadequate  exposure
o  sunlight  without  adequate  corrective  VD  intake  or  vita-
in  supplements  can  explain  the  high  VDD  prevalence  in
omen.1,8
Exposure  to  sunlight  is  the  main  source  of  VD  and,  at
est,  only  10%  of  the  body’s  reserves  are  provided  by  dietary
ntake.1 There  was  no  association  between  VDD  in  women
nd  sunlight  exposure  recommendations.  The  exposure  rec-
mmendations  for  obtaining  VD  take  into  account  factors
uch  as  UVB  radiation,  exposure  duration  and  exposed  body
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Table  3  Possible  factors  associated  with  non-sufﬁciency  of  vitamin  D  in  the  newborns.
Non-sufﬁciencyc Sufﬁciency  PR  (95%  CI)  pa
n  %  n  %
Season  of  the  year
Fall  37  20.3  14  31.8  1  0.42
Other seasons  145  79.7  30  68.2  0.96  (0.88--1.05)
Ethnicity
Caucasian 96  52.7  23  52.3  1  0.95
Non-Caucasian  86  47.3 21  47.7  0.99  (072--1.35)
Sunlight exposure  during  pregnancyb
Yes 58  45.5 9  37.5 1  0.36
No 64  52.5  15  62.5  0.93  (0.81--1.07)
Multivitamin  supplementsb
Yes  119  97.5  23  95.8  1  0.70
No 3  2.5  1  4.2  0.89  (0.50--1.58)
Place of  residence
Rural 28  15.4  6  13.6  1  0.77
Urban 154  84.6  38  86.4  0.88  (0.39--2.00)
Sunscreen protection  in  pregnancyb
Yes  45  36.9  10  41.7  1  0.66
No 77  66.1  14  58.3  1.03  (0.88--1.20)
PR prevalence ratio; 95% CI, conﬁdence interval.
a Poisson regression.
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db n=146 women answered.
c Non-sufﬁciency (deﬁciency + insufﬁciency of vitamin D).
area,  skin  pigmentation,  sunscreen  use,  time  of  the  day  of
exposure,  season,  latitude,  altitude  and  air  pollution.2
An  increase  in  the  sun’s  zenith  angle  during  the  winter
and  in  the  early  morning  and  late  afternoon  results  in  a
longer  path  for  UVB  rays  to  go  through  the  ozone  layer  and
be  absorbed.  This  explains  why,  above  and  below  33◦ of  lat-
itude,  little  or  no  VD  is  produced  in  the  skin  during  winter.
This  also  explains  why  the  synthesis  and  greater  absorption
of  VD  occur  only  between  10  am  and  3  pm  at  the  equator
or  in  places  closer  to  it.  Thus,  sunlight  exposure  of  arms
and  legs  for  5--30  min,  twice  a  week,  from  10  am  to  3  pm,  is
adequate.17
The  Brazilian  Society  of  Pediatrics  advises  that  children
younger  than  6 months  should  be  exposed  to  direct  sunlight
from  the  2nd  week  of  life  and  that  30  min/week  wearing
only  diapers  (6--8min  a  day,  3  times  a  week)  or  2h/week
with  partial  exposure  (17min  a  day),  exposing  the  face  and
hands,  are  enough.22 The  Brazilian  Recommendations  of
Endocrinology  and  Metabolism  advise  VD  supplementation
of  600  IU/day  for  pregnant  women  and  400  IU/day  for  chil-
t
t
f
Table  4  Multiple  regression  analysis  for  predictors  of  deﬁciency  
Variable  
Univariate  
ˇ  p-value  
Maternal  25(OH)D  0.73  <0.001  
Maternal alkaline  phosphatase  −0.029  0.024  
ˇ, coefﬁcient of regression; R2, univariate and multivariate linear regrren,  from  birth  to  the  ﬁrst  year  of  life,  as  they  belong  to
he  risk  group  for  VDD.20,23,24
Dark-skinned  individuals  have  difﬁculty  to  produce  VD.25
here  is  a  greater  afﬁnity  of  melanin,  as  the  melanocytes
re  more  active  and  easily  absorb  UVB  rays,  which  hinders
he  conversion  of  7-dehydrocholesterol  molecule  into  VD.  A
ark-skinned  individual  requires  10--50  times  more  sunlight
xposure  to  produce  the  same  amount  of  VD  in  comparison
o  light-skinned  individuals.25 However,  in  this  study,  skin
olor  showed  no  association  with  VD  non-sufﬁciency;  similar
esults  were  found  in  studies  carried  out  in  Greece  and  the
SA.10,21 Regarding  the  use  of  sunscreen,  a protection  factor
SPF)  of  15  reduces  VD  production  capacity  by  more  than
8%,26 although  most  of  the  women  in  the  study  with  VD  non-
ufﬁciency  reported  they  had  not  used  any  type  of  sunscreen
uring  pregnancy.There  was  an  association  between  25(OH)D  levels  of
he  women  and  the  newborns.  There  is  a  strong  associa-
ion  of  circulating  VD  levels  between  the  mother  and  the
etus,  so  that  maternal  VDD  reﬂects  in  neonatal  VDD,8,13
of  25(OH)D  (ng/mL)  in  the  newborns.
Vitamin  D  Newborn
Multivariate
R2 ˇ  p-value  R2
0.55  0.73  <0.001  0.58
0.022  −0.01  0.045
ession; p<0.05.
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xposing  children  to  the  risk  of  rickets.1 In  pregnancy,  the
ow  status  or  low  intake  of  VD  is  detrimental  to  both  the
other  and  the  fetus  and  predisposes  to  VD  deﬁciency
n  infancy.1 VDD  in  childhood  has  been  associated  with
ncreased  risk  of  lower  respiratory  tract  infections,  while
ow  VD  plasma  levels  in  cord  blood  were  associated  with
ncreased  risk  of  acute  respiratory  infections  and  wheezing
n  childhood.13
It  is  noteworthy  that  44.2%  (100)  of  the  women  in  this
tudy  had  high  AP  levels,  which  suggests  osteoblastic  activity
r  bone  mobilization  of  Ca  and  P  to  meet  the  high  require-
ents  of  the  fetus.  In  the  presence  of  mineral  deﬁciency,
here  is  increased  AP  synthesis.27
There  were  differences  in  the  levels  of  25(OH)D  of  new-
orns  with  non-sufﬁciency  and  sufﬁciency  of  VD  and  calcium.
n  the  diagnosis  of  rickets,  some  of  the  following  tests
re  altered:  serum  CA,  P,  PTH,  25(OH)D  or  AP.28 This  is
haracterized  as  an  important  result,  as  66  infants  had
DD,  four  had  severe  25(OH)D  deﬁciency,  with  VD  levels
10ng/mL  and  eight  had  hypocalcemia.  Severe  hypocal-
emia  with  or  without  seizures  is  a  common  complication
f  VDD  in  the  neonatal  period  or  early  childhood,  due  to
he  maternal  VDD,  along  with  inadequate  intake  of  VD  from
reast  milk  or  supplements.  This  condition  can  be  prevented
hrough  adequate  levels  of  maternal  VD  during  pregnancy
nd  supplementation  in  infancy.1 In  this  study,  PTH  levels  in
ord  blood  of  84.2%  of  the  infants  were  below  the  normal
evel.  It  is  suggested  that  this  fact  is  a  consequence  of  high
a  concentrations  that  exist  during  this  period  (supplied  by
aternal  Ca),5,29 without  the  need  to  stimulate  PTH  func-
ion  of  the  newborns  as  a  secondary  mechanism  of  Ca  and  P
obilization  from  bone,  which  are,  therefore,  physiological
echanisms.
This  study  has  limitations  due  to  its  cross-sectional  design
nd  also  because  some  risk  factors,  such  as  sunscreen  use,
se  of  multivitamin  supplements  and  amount  of  time  of
un  exposure  during  pregnancy  can  generate  recall  bias,
s  they  are  self-reported  information.  However,  the  results
btained  in  this  study  can  be  used  in  other  studies  and
n  other  populations,  especially  in  Latin  America,  where
hey  are  scarce,  as  the  assessed  sample  consisted  of  ran-
omly  selected  individuals  from  the  target  population,  so
hat  the  sample  was  representative  of  the  population.  More-
ver,  VDD  is  a  worldwide  problem  throughout  the  life  cycle.
t  is  suggested  that  further  studies  be  carried  out  to  better
nderstand  the  determinants  of  VD  levels  in  other  popula-
ion  groups.
Although  Brazil  is  a  tropical  country,  where  VDD  is  less
ikely  to  occur  than  in  countries  located  far  from  the  equa-
or,  a  high  prevalence  of  VD  non-sufﬁciency  was  identiﬁed  in
his  population  of  women  and  newborns,  which  can  be  pre-
ented  by  providing  guidelines  for  women  during  prenatal
are  and  the  postpartum  period  in  relation  to  sun  exposure
nd  VD  supplementation.  It  was  found  that  the  risk  factors
hat  contributed  to  the  low  levels  of  VD  in  newborns  were
aternal  25(OH)D  and  AP  levels.  Other  risk  factors,  namely
eason,  ethnicity,  place  of  residence,  sun  exposure,  use  of
ultivitamin  supplements  and  use  of  sunscreen,  were  not
ssociated  with  VDD  in  women  and  newborns.  Therefore,  the
mportance  of  assessing  the  nutritional  status  of  VD  during
other  and  child  routine  care  is  noteworthy.
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